[Administration of uridinediphosphoglucose (UDPG) and behavior of blood bilirubin in the newborn].
D001663:Bilirubin / Q000097:blood; D004200:Diseases in Twins / Q000188:drug therapy; D005947:Glucose / Q000627:therapeutic use*; D006801:Humans; D006932:Hyperbilirubinemia / Q000188:drug therapy*; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy; D007567:Jaundice, Neonatal / Q000188:drug therapy*; D009536:Niacinamide / Q000627:therapeutic use; D009702:Nucleoside Diphosphate Sugars / Q000627:therapeutic use; D014500:Uracil Nucleotides / Q000627:therapeutic use*
D009702:Nucleoside Diphosphate Sugars; D014500:Uracil Nucleotides; D009536:Niacinamide; D005947:Glucose; D001663:Bilirubin
Somministrazione di uridindifosfoglucosio (UDPG) e comportamento della bilirubinemia nel neonato.